Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Bibliographic Details
Main Authors:	Li, Xiaoling, Wang, Yuqin, Wang, Yan, Chen, Jianhua, Wu, Shengqi, Hu, Chenping, Yang, Yicheng, Rajan, Narayan, Papadimitropoulos, Manny, Chen, Yi, Peng, Tao, Chen, Wendong
Format:	Online
Language:	English
Published:	Springer International Publishing 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883204/

Similar Items

Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study
by: Wang, Yan, et al.
Published: (2014)

Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
by: Chen, Jianhua, et al.
Published: (2016)

Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
by: Song, Yuanlin, et al.
Published: (2014)

A retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma
by: Jin, Feng, et al.
Published: (2016)

Secreted frizzled-related protein 2 is epigenetically silenced and functions as a tumor suppressor in oral squamous cell carcinoma
by: XIAO, CAN, et al.
Published: (2014)

Irinotecan plus fluorouracil‐based regimen as second or third‐line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma
by: Wang, Xi, et al.
Published: (2015)

Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
by: Chen, Dan, et al.
Published: (2013)

BRAF-activated non-protein coding RNA (BANCR) advances the development of esophageal squamous cell carcinoma via cell cycle
by: Yang Chunxia, et al.
Published: (2017-04-01)

CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
by: Feng, Zhien, et al.
Published: (2011)

Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung Cancer
by: Hess, Lisa M., et al.
Published: (2015)

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
by: Chen, Wendong, et al.
Published: (2016)

A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients
by: Mo, Hongnan, et al.
Published: (2016)

Exploration of optimal time for initiating adjuvant chemotherapy after surgical resection: A retrospective study in Chinese patients with stage IIIA non‐small cell lung cancer in a single center
by: Zhu, Yixiang, et al.
Published: (2016)

Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
by: Yu Xun, et al.
Published: (2018-04-01)

Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer
by: Wang, Shuhang, et al.
Published: (2013)

Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
by: Wu, Wenting, et al.
Published: (2012)

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer
by: Chen, Yuan-Yuan, et al.
Published: (2015)

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line
by: Al-Farsi, Abdulaziz, et al.
Published: (2014)

Chaos in a second-order non-autonomous Wien-bridge oscillator without extra nonlinearity
by: Quan, Xu, et al.
Published: (2018)

Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
by: Chun, Sang Hoon, et al.
Published: (2011)

A Markov Model Approach Assessing the Cost of Illness of Generalized Anxiety Disorder in Canada
by: Bereza, Basil G., et al.
Published: (2012)

Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma
by: ZHANG, MINGBIN, et al.
Published: (2013)

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma
by: Cao, Wei, et al.
Published: (2016)

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
by: Bondarenko, Igor M, et al.
Published: (2015)

Smoking Affects Treatment Outcome in Patients with Resected Esophageal Squamous Cell Carcinoma Who Received Chemotherapy
by: Zheng, Yuzhen, et al.
Published: (2015)

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
by: Fosså, S. D., et al.
Published: (1990)

Northampton outcome for first and second line chemotherapy in non-small cell lung cancer: 5 years data
by: Eldeeb, Hany, et al.
Published: (2012)

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience
by: Gaviani, P., et al.
Published: (2013)

The Efficacy and Safety of Platinum/Vinorelbine as More Than Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Song, Ik-Chan, et al.
Published: (2015)

Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution
by: Lee, Seok Jeong, et al.
Published: (2014)

Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer
by: Lei, Tao, et al.
Published: (2016)

Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
by: Sheng, Jin, et al.
Published: (2016)

The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females
by: Zhou-Feng Chen, et al.
Published: (2018-08-01)

Concurrent Infection of Hepatitis B Virus Negatively Affects the Clinical Outcome and Prognosis of Patients with Non-Hodgkin’s Lymphoma after Chemotherapy
by: Chen, Jie, et al.
Published: (2013)

Efficacy and safety of chemotherapy for newly diagnosed advanced non-small cell lung cancer with venous thromboembolism
by: Zhang, Xueli, et al.
Published: (2015)

Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
by: Takagi, Yusuke, et al.
Published: (2013)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
by: Lu, Shao-Lun, et al.
Published: (2016)

Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study
by: Wu, Wan-Chen, et al.
Published: (2013)

Impact of age on adjuvant chemotherapy after radical resection in patients with non–small cell lung cancer
by: Zhai, Xiaoyu, et al.
Published: (2016)

Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
by: Liu, Lipin, et al.
Published: (2015)